To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone
H Chapter 181, Acts, Regular Session, 2026
Summary
The enacted amendment to the Medication‑Assisted Treatment Program Licensing Act adds a duty for methadone and buprenorphine clinics to provide non‑coercive contraceptive counseling and make long‑acting reversible contraception (LARC) available to patients. If a clinic does not have a qualified provider or equipment, it must refer patients to a licensed provider. The rule applies to all licensed MAT facilities and becomes effective 90 days after the governor’s signature (May 21 2026).
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when HB 4196 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 4196 freeOr ask your AI assistant about HB 4196 directly:
Add to Claude, ChatGPT or Cursor